These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 234594)

  • 21. Beta-adrenoceptor-blocking agents in the management of hypertension.
    Prichard BN
    Cardiology; 1979; 64 Suppl 1():44-87. PubMed ID: 42488
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-adrenergic blockade in some cardiovascular diseases.
    Tarazi RC
    Cardiovasc Clin; 1975; 7(1):173-85. PubMed ID: 238741
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension].
    Saitta A; Saitta MN; Bonaiuto M; Castaldo M; Sardo A; Messina A; Cinquegrani M; Squadrito G; Campo GM; Squadrito F
    Clin Ter; 1997; 148(5-6):237-47. PubMed ID: 9377859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical application of beta-blockaders].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Central effects of beta adrenergic receptor blockaders, obsidan and trasicor, in arterial hypertension].
    Kukes VG; Kazarian AB; Sozinov VN; Paramonov LV; Kniazev RP
    Sov Med; 1989; (8):61-3. PubMed ID: 2814668
    [No Abstract]   [Full Text] [Related]  

  • 33. [beta Blocking agents in arterial hypertension].
    Zacchello F
    Minerva Pediatr; 1977 Mar; 29(7):435-8. PubMed ID: 17060
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
    Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL
    Klin Med (Mosk); 1985 Aug; 63(8):41-8. PubMed ID: 2867248
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 37. Ten years experience with the use of B-adrenergic blockers in the pre-operative preparation of thyrotoxic patients.
    Bashir AY; Nasef A; Ibrahim AH; Kenawi MM; El-Malek WA; Ageeb M
    J Egypt Med Assoc; 1978; 61(1-2):1-9. PubMed ID: 41011
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
    Békés M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774
    [No Abstract]   [Full Text] [Related]  

  • 39. On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol.
    Bravo EL; Tarazi RC; Dustan HP
    J Lab Clin Med; 1974 Jan; 83(1):119-28. PubMed ID: 4808650
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade.
    Hansson L; Zweifler AJ
    Mich Med; 1973 Oct; 72(30):695-8. PubMed ID: 4147721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.